|Videos|July 26, 2022
Fezolinetant making waves for VMS
Author(s)Morgan Ebert
Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
20-year data show shifting causes of pregnancy-related death
2
Bladder symptoms during IVF carry systemic cues that extend beyond the urinary tract
3
FDA-cleared, post-intercourse vaginal health device launches
4
HCV testing and postpartum treatment gaps persist among pregnant women with opioid use disorder
5